Clinical Trials in Petah Tikva, Petah Tikva
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
Multiple Myeloma, Refractory
Karyopharm Therapeutics Inc127 enrolled16 locationsNCT04414475
Recruiting
Not Applicable
Early Transcatheter Mitral Valve Repair After Myocardial Infarction
Acute Mitral Regurgitation
Fundación para la Investigación Biosanitaria del Principado de Asturias250 enrolled32 locationsNCT06282042